Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4N7J

Tailoring Small Molecules for an Allosteric Site on Procaspase-6

Summary for 4N7J
Entry DOI10.2210/pdb4n7j/pdb
Related4N5D 4N6G 4N7M 4NBK 4NBL 4NBN
DescriptorCaspase-6, PHOSPHATE ION, 3-(pyrrolidin-1-yl)isoquinolin-1(2H)-one, ... (4 entities in total)
Functional Keywordsprocaspse-6, caspase-6 zymogen, allosteric, structure based drug design, caspase, cysteine protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm: P55212
Total number of polymer chains2
Total formula weight65316.83
Authors
Murray, J.M.,Steffek, M. (deposition date: 2013-10-15, release date: 2013-12-18, Last modification date: 2024-02-28)
Primary citationMurray, J.,Giannetti, A.M.,Steffek, M.,Gibbons, P.,Hearn, B.R.,Cohen, F.,Tam, C.,Pozniak, C.,Bravo, B.,Lewcock, J.,Jaishankar, P.,Ly, C.Q.,Zhao, X.,Tang, Y.,Chugha, P.,Arkin, M.R.,Flygare, J.,Renslo, A.R.
Tailoring small molecules for an allosteric site on procaspase-6.
Chemmedchem, 9:73-77, 2014
Cited by
PubMed Abstract: Although they represent attractive therapeutic targets, caspases have so far proven recalcitrant to the development of drugs targeting the active site. Allosteric modulation of caspase activity is an alternate strategy that potentially avoids the need for anionic and electrophilic functionality present in most active-site inhibitors. Caspase-6 has been implicated in neurodegenerative disease, including Huntington's and Alzheimer's diseases. Herein we describe a fragment-based lead discovery effort focused on caspase-6 in its active and zymogen forms. Fragments were identified for procaspase-6 using surface plasmon resonance methods and subsequently shown by X-ray crystallography to bind a putative allosteric site at the dimer interface. A fragment-merging strategy was employed to produce nanomolar-affinity ligands that contact residues in the L2 loop at the dimer interface, significantly stabilizing procaspase-6. Because rearrangement of the L2 loop is required for caspase-6 activation, our results suggest a strategy for the allosteric control of caspase activation with drug-like small molecules.
PubMed: 24259468
DOI: 10.1002/cmdc.201300424
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.673 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon